Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, AB.
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB.
Curr Oncol. 2020 Oct;27(5):e516-e523. doi: 10.3747/co.27.6751. Epub 2020 Oct 1.
The understanding of the biology and epidemiology of, and the optimal therapeutic strategies for, breast cancer (bca) in younger women is limited. We present the rationale, design, and initial recruitment of Reducing the Burden of Breast Cancer in Young Women (ruby), a unique national prospective cohort study designed to examine the diagnosis, treatment, quality of life, and outcomes from the time of diagnosis for young women with bca.
Over a 4-year period at 33 sites across Canada, the ruby study will use a local and virtual recruitment model to enrol 1200 women with bca who are 40 years of age or younger at the time of diagnosis, before initiation of any treatment. At a minimum, comprehensive patient, tumour, and treatment data will be collected to evaluate recurrence and survival. Patients may opt to complete patient-reported questionnaires, to provide blood and tumour samples, and to be contacted for future research, forming the core dataset from which 4 subprojects evaluating genetics, lifestyle factors, fertility, and local management or delivery of care will be performed.
The ruby study will be the most comprehensive repository of data, biospecimens, and patient-reported outcomes ever collected with respect to young women with bca from the time of diagnosis, enabling research unique to that population now and into the future. This research model could be used for other oncology settings in Canada.
对于年轻女性乳腺癌(bca)的生物学和流行病学特征,以及最佳治疗策略,人们的了解有限。我们提出了减少年轻女性乳腺癌负担(ruby)研究的基本原理、设计和初步入组情况,这是一项全国性的前瞻性队列研究,旨在从诊断时开始,对患有 bca 的年轻女性的诊断、治疗、生活质量和结局进行研究。
在加拿大 33 个地点的 4 年期间,ruby 研究将使用本地和虚拟招募模式,招募 1200 名年龄在 40 岁及以下的 bca 女性患者,这些患者在开始任何治疗之前被诊断为 bca。至少,将收集全面的患者、肿瘤和治疗数据,以评估复发和生存情况。患者可以选择完成患者报告的问卷,提供血液和肿瘤样本,并在未来的研究中被联系,形成核心数据集,在此基础上将开展 4 个子项目,评估遗传学、生活方式因素、生育能力以及局部管理或护理的提供。
ruby 研究将是迄今为止从诊断时开始针对年轻女性 bca 收集的最全面的数据、生物样本和患者报告结局的存储库,使现在和未来能够针对该人群开展独特的研究。这种研究模式可用于加拿大的其他肿瘤学领域。